Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

EU GDP Guideline revised again

Thursday the 28th November 2013

On 5 November 2013 a revision to the GDP Guidelines, which completely replaces the version that was issued in March 2013, was published. The November version, which became effective on 24 November 2013, corrects factual mistakes identified in sections 5.5 and 6.3 of the March 2013 Guidelines.

... Read more

Packaging Validation: E&L Detection

Wednesday the 27th November 2013

Improve patient safety and avoid costly product-launch delays

By Kurt L. Moyer and James R. Scull, NSF Health Sciences

Well-documented incidents of contaminants leaching from containers and packaging has brought heightened awareness of the health risks posed by extractables and leachables in...

Read more

Drug Shortages

Tuesday the 12th November 2013

In the past two weeks both the FDA and the EMA have made moves to try to respond to growing concern over drug shortages. These measures are:

US FDA

The FDA proposed a new rule that would require drug manufacturers to notify the FDA at least six months in advance of a possible interruption i...

Read more

Presence of NSF Health Sciences at recent PDA events in Europe

Friday the 8th November 2013

Two recent PDA events in Europe gave us the opportunity to spread the word about the training, auditing and consulting services that NSF Health Sciences offers in four local European languages, namely English, German, French and Italian.

The first event was the PDA Meeting on Pharmaceutical F...

Read more

EMA/FDA Paper on Design Space Verification

Wednesday the 6th November 2013

On the 4th November the EMA and FDA published a second Q&A paper resulting from their joint review of QbD submissions. This document is on the subject of ‘Design Space Verification’. A design space is established at early stages of product development, it is typically developed based on exper...

Read more

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Boston and Ann Arbor, USA

A word from NSF Health Sciences

The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF Health Sciences 2014

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: pharmamail@nsf.org
US Office: NSF Health Sciences, 6th floor, 129 South St, Boston, MA 02111 | Tel: 1-857-277-0060 | Fax: 1-857-284-7207 | Email: USpharma@nsf.org